PMID- 3490784
OWN - NLM
STAT- MEDLINE
DCOM- 19861217
LR  - 20190716
IS  - 0002-922X (Print)
IS  - 0002-922X (Linking)
VI  - 140
IP  - 12
DP  - 1986 Dec
TI  - Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of 
      a new vaccine.
PG  - 1226-30
AB  - The introduction of Haemophilus Influenzae type b (Hib) polysaccharide vaccine in 
      1985 provided an opportunity to study the extent to which physicians have adopted 
      the use of the new vaccine in their routine practice behavior, the factors that 
      predict Hib vaccine use by physicians, and how physicians have chosen to deal 
      with differing recommendations for its administration. We surveyed all physicians 
      providing primary care to children in New Mexico six to eight months after 
      vaccine licensure to assess their knowledge of existing recommendations and their 
      current behavior regarding use of the Hib vaccine. Of the 369 primary care 
      physicians who responded, 100% of pediatricians, 98% of family practitioners, and 
      91% of general practitioners were aware that a vaccine against invasive Hib 
      disease had been licensed. Sixty-three percent of physicians surveyed were 
      currently using the vaccine. Vaccine usage varied significantly by specialty, 
      with 86% of pediatricians reporting use compared with 61% of family practitioners 
      and 31% of general practitioners. Physicians were significantly more likely to 
      use Hib vaccine if they were young and if they worked in the private sector 
      rather than the public sector. The three sets of recommendations for Hib vaccine 
      use had been widely read; 85% of respondents had read at least one set. 
      Practitioners confronted with differing recommendations had elected to give the 
      vaccine permissively within existing guidelines. Our findings suggest that 
      practitioners have adapted quickly to the introduction of Hib vaccine but that 
      nonuse of the vaccine in the public sector remains an obstacle to full 
      implementation of this prevention strategy.
FAU - Cochi, S L
AU  - Cochi SL
FAU - Fleming, D W
AU  - Fleming DW
FAU - Hull, H F
AU  - Hull HF
FAU - Preblud, S R
AU  - Preblud SR
FAU - Orenstein, W A
AU  - Orenstein WA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am J Dis Child
JT  - American journal of diseases of children (1960)
JID - 0370471
RN  - 0 (Bacterial Vaccines)
RN  - 0 (Haemophilus Vaccines)
RN  - 0 (Haemophilus influenzae type b polysaccharide vaccine)
RN  - 0 (Polysaccharides, Bacterial)
SB  - IM
MH  - *Attitude of Health Personnel
MH  - Bacterial Capsules
MH  - *Bacterial Vaccines
MH  - Diffusion of Innovation
MH  - Drug Utilization
MH  - *Haemophilus Vaccines
MH  - Haemophilus influenzae/*immunology
MH  - Humans
MH  - New Mexico
MH  - *Polysaccharides, Bacterial
MH  - *Practice Patterns, Physicians'
EDAT- 1986/12/01 00:00
MHDA- 1986/12/01 00:01
CRDT- 1986/12/01 00:00
PHST- 1986/12/01 00:00 [pubmed]
PHST- 1986/12/01 00:01 [medline]
PHST- 1986/12/01 00:00 [entrez]
AID - 10.1001/archpedi.1986.02140260028019 [doi]
PST - ppublish
SO  - Am J Dis Child. 1986 Dec;140(12):1226-30. doi: 
      10.1001/archpedi.1986.02140260028019.